India’s vaccine manufacturing set to soar

Chennai, India: Professor Steven Myint, chairman of Chennai-based Green Signal Bio Pharma, predicts that India’s vaccine manufacturing will grow from current revenues of $665m to $800m soon.

India has emerged as a key vaccine manufacturer in recent times. It already produces 60% of the global health vaccines, according to a report in India Post. Vaccines have emerged as one of the growth drivers of the global pharmaceutical industry, said Myint on a recent visit to New York.

The scientist said that the scare of avian flu, bio-terrorism organisms and new emerging infections like SARS and the introduction of cancer and rotavirus vaccines have led to phenomenal growth in the vaccine market in the last few years.

Exports have a major share in the Indian vaccine market, with 70% of vaccines being exported. Of the total domestic market, the private sector’s share stood at $120m or at 40%.

However, it is estimated that in the future more opportunities for manufacture and sales of vaccines will emerge from developing nations such as India and China, said Myint.

WORLD NEWS

Carrier’s NaturaLine cools grocery kiosks

Singapore: Robotic kiosks that provide automated and contactless dispensing of groceries for consumers are being sustainably refrigerated by Carrier Transicold NaturaLine units, the world’s first …

READ THE FULL STORY >

Amarillo Thermo King is 2020 North America Dealer of the Year

Minneapolis, Minnesota, USA: Thermo King presented its 2020 North America Dealer of the Year award to Thermo King Amarillo. The award was the culmination of …

READ THE FULL STORY >

Irish freight finds new routes

Dublin, Ireland: The volume of freight shipped across the Irish Sea from the Republic of Ireland to Britain is down significantly despite government claims that …

READ THE FULL STORY >

Leman expands pharma warehouse capacity

Greve, Denmark: International freight forwarding and logistics company Leman is expanding its pharmaceutical warehousing capacity in Greve. In collaboration with two of the company’s pharmaceutical …

READ THE FULL STORY >

WHAT’S ON

Latest Tweets

@MartinSLewis Thought I heard Rishi Sunak say that SEISS 5 would cover May-September (same as furlough?). Might be wrong!

© 2021 Global Cold Chain News | Terms of use | Privacy Policy
Commercial Transport Publishing Limited, registered in England and Wales, Company No: 6453302. Registered Office: 6 Corunna Court, Corunna Road, Warwick CV34 5HQ